Browse by Poster Title

• C
• P-183
  Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of the Randomized Controlled Trials Published on COVID-19
  Favorite
• P-182
  Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of the Research Articles Published on COVID-19
  Favorite
• P-298
  Carboplatin Appropriateness and Rationality Assessment
  Favorite
• P-303
  Cardiovascular Safety Assessment of Febuxostat and Allopurinol in the Real World: A Retrospective Cohort Study
  Favorite
• P-381
  Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
  Favorite
• P-373
  Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
  Favorite
• P-424
  Challenges in Studying COVID-19 Treatments in Real-world Hospital Datasets: A Case Study of Tocilizumab
  Favorite
• P-481
  Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large Us-based Real-world Cohort
  Favorite
• P-405
  Characteristics of Patients Initiating Spiriva Respimat for Asthma in the UK
  Favorite
• P-392
  Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) Initiating Nintedanib or Pirfenidone Treatment Compared with Untreated Patients in the US
  Favorite
• P-311
  Characterization of Polypharmacy in Middle-aged and Elderly Adults in the UK: An Analysis of 0.5 million People in UK Biobank
  Favorite
• P-100
  Characterization of Real-world Data Sources to Support Observational Studies of Biologics, Including Biosimilars in Oncology
  Favorite
• P-449
  Characterizing “long-covid” Using Real World Data: Post-discharge Clinical Course Among Patients Initially Hospitalized for COVID-19
  Favorite
• P-097
  Characterizing Patients Using Abuse-deterrent Formulations of Extended-release Opioid Analgesics
  Favorite
• P-190
  Characterizing Real-world Treatment Patterns Among Patients Hospitalized Due to sars-cov-2
  Favorite
• P-430
  Chronic Obstructive Pulmonary Disease and Drug-resistant Pseudomonas in Patients Hospitalized with Community-acquired Bacterial Pneumonia
  Favorite
• P-254
  Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer
  Favorite
• P-622
  Claims-based Algorithm for Defining Asthma GINA Steps in US Healthcare Database
  Favorite
• P-090
  Classification of Gabapentinoids as Controlled Drugs Reduced Gabapentinoid Prescriptions in Primary Care in England
  Favorite
• P-089
  Clinical and Cost-saving Effects of the Drug Utilization Review Modernization Pilot Project in Inpatient and Outpatient Settings in Korea
  Favorite
• P-018
  Clinical Characteristics and Biomarkers of sars-cov-2 Infection in Patients Treated with Remdesivir in Hospital - A Population Based Cohort Study
  Favorite
• P-577
  Clinical Characteristics of Pediatric Patients Hospitalized with COVID-19 in an Electronic Health Record Database
  Favorite
• P-394
  Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
  Favorite
• P-121
  Clinical Notes versus Diagnosis Codes in Identification and Characterization of Women with Endometriosis
  Favorite
• P-276
  Clinical Outcomes Among Relapsed/refractory (R/R) Adult and Pediatric Classical Hodgkin’s Lymphoma (cHL) Patients: A Global Systematic Literature Review (SLR)
  Favorite
• P-050
  Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results
  Favorite
• P-114
  Comedication of Opioids with Benzodiazepines, Gabapentinoids Among Caregivers of Children with Special Healthcare Needs
  Favorite
• P-175
  Community Pharmacists Managed Patient Safety Program with Minimal Patient Contact for Elderly Patients in Ajman, United Arab Emirates
  Favorite
• P-569
  Comorbidities Associated with Insomnia Stratified by Age and Sex
  Favorite
• P-463
  Comparative Analysis on the Evolution of Antimicrobial Resistance Surveillance and Governance Between China and the United States
  Favorite
• P-096
  Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
  Favorite
• P-032
  Comparative Effectiveness and Safety of Low versus High Dose Rivaroxaban and Apixaban for Atrial Fibrillation: A Propensity Score-matched Cohort Study
  Favorite
• P-164
  Comparative Effectiveness and Safety of Prasugrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Transluminal Coronary Angioplasty
  Favorite
• P-419
  Comparative Risk of Delirium Associated with Oxybutynin and Solifenacin in Older Adults
  Favorite
• P-493
  Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States
  Favorite
• P-380
  Comparison of 21-year Sex-specific Fracture Incidence Rates Between Type 1 and Type 2 Diabetics and Non-diabetics in Denmark (1997 – 2017)
  Favorite
• P-105
  Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
  Favorite
• P-201
  Comparison of Quality of Life Between Men and Women with Chronic Liver Diseases Using Chronic Liver Disease Questionnaire (CLDQ): A Meta-analysis
  Favorite
• P-115
  Comparison of Rheumatic Patients Across Body Mass Index Categories
  Favorite
• P-325
  Comparison of Safety Profiles by Chronic Health Conditions in Korean Adults with Egg-based Inactivated Quadrivalent Influenza Vaccines (QIV, GC3110A)
  Favorite
• P-435
  Comparison of Safety Signals Between Selective Serotonin-reuptake Inhibitors (SSRI) and Serotonin–norepinephrine Reuptake Inhibitors (SNRI) Employing Fda Adverse Event Reporting System (FAERS) Database
  Favorite
• P-632
  Comparison of the Incidence of Acute Pancreatitis Among New Users of Fluoxetine, Citalopram, and Other Selective Serotonin Reuptake Inhibitors: A Danish Register-based Cohort Study
  Favorite
• P-017
  Comparison of the Incidence of Bleeding Between Anti-influenza Drugs Among Outpatients for the Influenza Virus Infection: A Retrospective Study Using an Employment-based Health Insurance Claims Database in Japan
  Favorite
• P-128
  Comparisons of Effect Estimates of 12 Prescribing Cascades Using Prescription Sequence Symmetry Analysis
  Favorite
• P-524
  Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis
  Favorite
• P-139
  Consumption Patterns of Chronic Medication During the COVID-19 Pandemic in Portugal
  Favorite
• P-120
  Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
  Favorite
• P-134
  Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
  Favorite
• P-133
  Cost-related Nonadherence for Prescription Medications: A Cross-sectional Study in Jordan
  Favorite
• P-508
  COVID-19 Symptom Severity Among Smokers: Insights from a Direct-to-community Registry
  Favorite
• P-351
  COVID-19 Treatment Approaches Among Hospitalized Patients in a National Healthcare System
  Favorite
• P-451
  Creating High Quality External Control Arms from RWD in Support of Regulatory Decision Making
  Favorite